Global Peripheral Intervention Drug Eluting Devices Market Research Report 2026(Status and Outlook)
Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
The global Peripheral Intervention Drug Eluting Devices market size was estimated at USD 7836.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Peripheral Intervention Drug Eluting Devices market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Peripheral Intervention Drug Eluting Devices market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Peripheral Intervention Drug Eluting Devices market.
Global Peripheral Intervention Drug Eluting Devices Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. BardInc.
Abbott
The Lubrizol Corporation
Terumo Corporation
Market Segmentation (by Type)
Drug-Eluting Balloons
Drug-Eluting Stents
Market Segmentation (by Application)
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peripheral Intervention Drug Eluting Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Peripheral Intervention Drug Eluting Devices, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Peripheral Intervention Drug Eluting Devices market size was estimated at USD 7836.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Peripheral Intervention Drug Eluting Devices market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Peripheral Intervention Drug Eluting Devices market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Peripheral Intervention Drug Eluting Devices market.
Global Peripheral Intervention Drug Eluting Devices Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. BardInc.
Abbott
The Lubrizol Corporation
Terumo Corporation
Market Segmentation (by Type)
Drug-Eluting Balloons
Drug-Eluting Stents
Market Segmentation (by Application)
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Peripheral Intervention Drug Eluting Devices Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peripheral Intervention Drug Eluting Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Peripheral Intervention Drug Eluting Devices, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Peripheral Intervention Drug Eluting Devices
1.2 Key Market Segments
1.2.1 Peripheral Intervention Drug Eluting Devices Segment by Type
1.2.2 Peripheral Intervention Drug Eluting Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Peripheral Intervention Drug Eluting Devices Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Peripheral Intervention Drug Eluting Devices Product Life Cycle
3.3 Global Peripheral Intervention Drug Eluting Devices Sales by Manufacturers (2020-2025)
3.4 Global Peripheral Intervention Drug Eluting Devices Revenue Market Share by Manufacturers (2020-2025)
3.5 Peripheral Intervention Drug Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peripheral Intervention Drug Eluting Devices Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Peripheral Intervention Drug Eluting Devices Market Competitive Situation and Trends
3.8.1 Peripheral Intervention Drug Eluting Devices Market Concentration Rate
3.8.2 Global 5 and 10 Largest Peripheral Intervention Drug Eluting Devices Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Peripheral Intervention Drug Eluting Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Peripheral Intervention Drug Eluting Devices Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Peripheral Intervention Drug Eluting Devices Market
5.7 ESG Ratings of Leading Companies
6 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Type (2020-2025)
6.3 Global Peripheral Intervention Drug Eluting Devices Market Size by Type (2020-2025)
6.4 Global Peripheral Intervention Drug Eluting Devices Price by Type (2020-2025)
7 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peripheral Intervention Drug Eluting Devices Market Sales by Application (2020-2025)
7.3 Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) by Application (2020-2025)
7.4 Global Peripheral Intervention Drug Eluting Devices Sales Growth Rate by Application (2020-2025)
8 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET SALES BY REGION
8.1 Global Peripheral Intervention Drug Eluting Devices Sales by Region
8.1.1 Global Peripheral Intervention Drug Eluting Devices Sales by Region
8.1.2 Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Region
8.2 Global Peripheral Intervention Drug Eluting Devices Market Size by Region
8.2.1 Global Peripheral Intervention Drug Eluting Devices Market Size by Region
8.2.2 Global Peripheral Intervention Drug Eluting Devices Market Size by Region
8.3 North America
8.3.1 North America Peripheral Intervention Drug Eluting Devices Sales by Country
8.3.2 North America Peripheral Intervention Drug Eluting Devices Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Peripheral Intervention Drug Eluting Devices Sales by Country
8.4.2 Europe Peripheral Intervention Drug Eluting Devices Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Peripheral Intervention Drug Eluting Devices Sales by Region
8.5.2 Asia Pacific Peripheral Intervention Drug Eluting Devices Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Peripheral Intervention Drug Eluting Devices Sales by Country
8.6.2 South America Peripheral Intervention Drug Eluting Devices Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales by Region
8.7.2 Middle East and Africa Peripheral Intervention Drug Eluting Devices Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Peripheral Intervention Drug Eluting Devices by Region(2020-2025)
9.2 Global Peripheral Intervention Drug Eluting Devices Revenue Market Share by Region (2020-2025)
9.3 Global Peripheral Intervention Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Peripheral Intervention Drug Eluting Devices Production
9.4.1 North America Peripheral Intervention Drug Eluting Devices Production Growth Rate (2020-2025)
9.4.2 North America Peripheral Intervention Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Peripheral Intervention Drug Eluting Devices Production
9.5.1 Europe Peripheral Intervention Drug Eluting Devices Production Growth Rate (2020-2025)
9.5.2 Europe Peripheral Intervention Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Peripheral Intervention Drug Eluting Devices Production (2020-2025)
9.6.1 Japan Peripheral Intervention Drug Eluting Devices Production Growth Rate (2020-2025)
9.6.2 Japan Peripheral Intervention Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Peripheral Intervention Drug Eluting Devices Production (2020-2025)
9.7.1 China Peripheral Intervention Drug Eluting Devices Production Growth Rate (2020-2025)
9.7.2 China Peripheral Intervention Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Medtronic plc
10.1.1 Medtronic plc Basic Information
10.1.2 Medtronic plc Peripheral Intervention Drug Eluting Devices Product Overview
10.1.3 Medtronic plc Peripheral Intervention Drug Eluting Devices Product Market Performance
10.1.4 Medtronic plc Business Overview
10.1.5 Medtronic plc SWOT Analysis
10.1.6 Medtronic plc Recent Developments
10.2 Boston Scientific Corporation
10.2.1 Boston Scientific Corporation Basic Information
10.2.2 Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Product Overview
10.2.3 Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Product Market Performance
10.2.4 Boston Scientific Corporation Business Overview
10.2.5 Boston Scientific Corporation SWOT Analysis
10.2.6 Boston Scientific Corporation Recent Developments
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Basic Information
10.3.2 Abbott Laboratories Peripheral Intervention Drug Eluting Devices Product Overview
10.3.3 Abbott Laboratories Peripheral Intervention Drug Eluting Devices Product Market Performance
10.3.4 Abbott Laboratories Business Overview
10.3.5 Abbott Laboratories SWOT Analysis
10.3.6 Abbott Laboratories Recent Developments
10.4 Cardinal Health
10.4.1 Cardinal Health Basic Information
10.4.2 Cardinal Health Peripheral Intervention Drug Eluting Devices Product Overview
10.4.3 Cardinal Health Peripheral Intervention Drug Eluting Devices Product Market Performance
10.4.4 Cardinal Health Business Overview
10.4.5 Cardinal Health Recent Developments
10.5 B. Braun Melsungen AG
10.5.1 B. Braun Melsungen AG Basic Information
10.5.2 B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Product Overview
10.5.3 B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Product Market Performance
10.5.4 B. Braun Melsungen AG Business Overview
10.5.5 B. Braun Melsungen AG Recent Developments
10.6 Biosensors International Group Ltd.
10.6.1 Biosensors International Group Ltd. Basic Information
10.6.2 Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Product Overview
10.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Product Market Performance
10.6.4 Biosensors International Group Ltd. Business Overview
10.6.5 Biosensors International Group Ltd. Recent Developments
10.7 C.R. BardInc.
10.7.1 C.R. BardInc. Basic Information
10.7.2 C.R. BardInc. Peripheral Intervention Drug Eluting Devices Product Overview
10.7.3 C.R. BardInc. Peripheral Intervention Drug Eluting Devices Product Market Performance
10.7.4 C.R. BardInc. Business Overview
10.7.5 C.R. BardInc. Recent Developments
10.8 Abbott
10.8.1 Abbott Basic Information
10.8.2 Abbott Peripheral Intervention Drug Eluting Devices Product Overview
10.8.3 Abbott Peripheral Intervention Drug Eluting Devices Product Market Performance
10.8.4 Abbott Business Overview
10.8.5 Abbott Recent Developments
10.9 The Lubrizol Corporation
10.9.1 The Lubrizol Corporation Basic Information
10.9.2 The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Product Overview
10.9.3 The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Product Market Performance
10.9.4 The Lubrizol Corporation Business Overview
10.9.5 The Lubrizol Corporation Recent Developments
10.10 Terumo Corporation
10.10.1 Terumo Corporation Basic Information
10.10.2 Terumo Corporation Peripheral Intervention Drug Eluting Devices Product Overview
10.10.3 Terumo Corporation Peripheral Intervention Drug Eluting Devices Product Market Performance
10.10.4 Terumo Corporation Business Overview
10.10.5 Terumo Corporation Recent Developments
11 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET FORECAST BY REGION
11.1 Global Peripheral Intervention Drug Eluting Devices Market Size Forecast
11.2 Global Peripheral Intervention Drug Eluting Devices Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country
11.2.3 Asia Pacific Peripheral Intervention Drug Eluting Devices Market Size Forecast by Region
11.2.4 South America Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Peripheral Intervention Drug Eluting Devices by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Peripheral Intervention Drug Eluting Devices Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Peripheral Intervention Drug Eluting Devices by Type (2026-2035)
12.1.2 Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Peripheral Intervention Drug Eluting Devices by Type (2026-2035)
12.2 Global Peripheral Intervention Drug Eluting Devices Market Forecast by Application (2026-2035)
12.2.1 Global Peripheral Intervention Drug Eluting Devices Sales (K Units) Forecast by Application
12.2.2 Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Peripheral Intervention Drug Eluting Devices
1.2 Key Market Segments
1.2.1 Peripheral Intervention Drug Eluting Devices Segment by Type
1.2.2 Peripheral Intervention Drug Eluting Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Peripheral Intervention Drug Eluting Devices Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Peripheral Intervention Drug Eluting Devices Product Life Cycle
3.3 Global Peripheral Intervention Drug Eluting Devices Sales by Manufacturers (2020-2025)
3.4 Global Peripheral Intervention Drug Eluting Devices Revenue Market Share by Manufacturers (2020-2025)
3.5 Peripheral Intervention Drug Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peripheral Intervention Drug Eluting Devices Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Peripheral Intervention Drug Eluting Devices Market Competitive Situation and Trends
3.8.1 Peripheral Intervention Drug Eluting Devices Market Concentration Rate
3.8.2 Global 5 and 10 Largest Peripheral Intervention Drug Eluting Devices Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Peripheral Intervention Drug Eluting Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Peripheral Intervention Drug Eluting Devices Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Peripheral Intervention Drug Eluting Devices Market
5.7 ESG Ratings of Leading Companies
6 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Type (2020-2025)
6.3 Global Peripheral Intervention Drug Eluting Devices Market Size by Type (2020-2025)
6.4 Global Peripheral Intervention Drug Eluting Devices Price by Type (2020-2025)
7 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peripheral Intervention Drug Eluting Devices Market Sales by Application (2020-2025)
7.3 Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) by Application (2020-2025)
7.4 Global Peripheral Intervention Drug Eluting Devices Sales Growth Rate by Application (2020-2025)
8 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET SALES BY REGION
8.1 Global Peripheral Intervention Drug Eluting Devices Sales by Region
8.1.1 Global Peripheral Intervention Drug Eluting Devices Sales by Region
8.1.2 Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Region
8.2 Global Peripheral Intervention Drug Eluting Devices Market Size by Region
8.2.1 Global Peripheral Intervention Drug Eluting Devices Market Size by Region
8.2.2 Global Peripheral Intervention Drug Eluting Devices Market Size by Region
8.3 North America
8.3.1 North America Peripheral Intervention Drug Eluting Devices Sales by Country
8.3.2 North America Peripheral Intervention Drug Eluting Devices Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Peripheral Intervention Drug Eluting Devices Sales by Country
8.4.2 Europe Peripheral Intervention Drug Eluting Devices Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Peripheral Intervention Drug Eluting Devices Sales by Region
8.5.2 Asia Pacific Peripheral Intervention Drug Eluting Devices Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Peripheral Intervention Drug Eluting Devices Sales by Country
8.6.2 South America Peripheral Intervention Drug Eluting Devices Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales by Region
8.7.2 Middle East and Africa Peripheral Intervention Drug Eluting Devices Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Peripheral Intervention Drug Eluting Devices by Region(2020-2025)
9.2 Global Peripheral Intervention Drug Eluting Devices Revenue Market Share by Region (2020-2025)
9.3 Global Peripheral Intervention Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Peripheral Intervention Drug Eluting Devices Production
9.4.1 North America Peripheral Intervention Drug Eluting Devices Production Growth Rate (2020-2025)
9.4.2 North America Peripheral Intervention Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Peripheral Intervention Drug Eluting Devices Production
9.5.1 Europe Peripheral Intervention Drug Eluting Devices Production Growth Rate (2020-2025)
9.5.2 Europe Peripheral Intervention Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Peripheral Intervention Drug Eluting Devices Production (2020-2025)
9.6.1 Japan Peripheral Intervention Drug Eluting Devices Production Growth Rate (2020-2025)
9.6.2 Japan Peripheral Intervention Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Peripheral Intervention Drug Eluting Devices Production (2020-2025)
9.7.1 China Peripheral Intervention Drug Eluting Devices Production Growth Rate (2020-2025)
9.7.2 China Peripheral Intervention Drug Eluting Devices Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Medtronic plc
10.1.1 Medtronic plc Basic Information
10.1.2 Medtronic plc Peripheral Intervention Drug Eluting Devices Product Overview
10.1.3 Medtronic plc Peripheral Intervention Drug Eluting Devices Product Market Performance
10.1.4 Medtronic plc Business Overview
10.1.5 Medtronic plc SWOT Analysis
10.1.6 Medtronic plc Recent Developments
10.2 Boston Scientific Corporation
10.2.1 Boston Scientific Corporation Basic Information
10.2.2 Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Product Overview
10.2.3 Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Product Market Performance
10.2.4 Boston Scientific Corporation Business Overview
10.2.5 Boston Scientific Corporation SWOT Analysis
10.2.6 Boston Scientific Corporation Recent Developments
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Basic Information
10.3.2 Abbott Laboratories Peripheral Intervention Drug Eluting Devices Product Overview
10.3.3 Abbott Laboratories Peripheral Intervention Drug Eluting Devices Product Market Performance
10.3.4 Abbott Laboratories Business Overview
10.3.5 Abbott Laboratories SWOT Analysis
10.3.6 Abbott Laboratories Recent Developments
10.4 Cardinal Health
10.4.1 Cardinal Health Basic Information
10.4.2 Cardinal Health Peripheral Intervention Drug Eluting Devices Product Overview
10.4.3 Cardinal Health Peripheral Intervention Drug Eluting Devices Product Market Performance
10.4.4 Cardinal Health Business Overview
10.4.5 Cardinal Health Recent Developments
10.5 B. Braun Melsungen AG
10.5.1 B. Braun Melsungen AG Basic Information
10.5.2 B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Product Overview
10.5.3 B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Product Market Performance
10.5.4 B. Braun Melsungen AG Business Overview
10.5.5 B. Braun Melsungen AG Recent Developments
10.6 Biosensors International Group Ltd.
10.6.1 Biosensors International Group Ltd. Basic Information
10.6.2 Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Product Overview
10.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Product Market Performance
10.6.4 Biosensors International Group Ltd. Business Overview
10.6.5 Biosensors International Group Ltd. Recent Developments
10.7 C.R. BardInc.
10.7.1 C.R. BardInc. Basic Information
10.7.2 C.R. BardInc. Peripheral Intervention Drug Eluting Devices Product Overview
10.7.3 C.R. BardInc. Peripheral Intervention Drug Eluting Devices Product Market Performance
10.7.4 C.R. BardInc. Business Overview
10.7.5 C.R. BardInc. Recent Developments
10.8 Abbott
10.8.1 Abbott Basic Information
10.8.2 Abbott Peripheral Intervention Drug Eluting Devices Product Overview
10.8.3 Abbott Peripheral Intervention Drug Eluting Devices Product Market Performance
10.8.4 Abbott Business Overview
10.8.5 Abbott Recent Developments
10.9 The Lubrizol Corporation
10.9.1 The Lubrizol Corporation Basic Information
10.9.2 The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Product Overview
10.9.3 The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Product Market Performance
10.9.4 The Lubrizol Corporation Business Overview
10.9.5 The Lubrizol Corporation Recent Developments
10.10 Terumo Corporation
10.10.1 Terumo Corporation Basic Information
10.10.2 Terumo Corporation Peripheral Intervention Drug Eluting Devices Product Overview
10.10.3 Terumo Corporation Peripheral Intervention Drug Eluting Devices Product Market Performance
10.10.4 Terumo Corporation Business Overview
10.10.5 Terumo Corporation Recent Developments
11 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET FORECAST BY REGION
11.1 Global Peripheral Intervention Drug Eluting Devices Market Size Forecast
11.2 Global Peripheral Intervention Drug Eluting Devices Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country
11.2.3 Asia Pacific Peripheral Intervention Drug Eluting Devices Market Size Forecast by Region
11.2.4 South America Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Peripheral Intervention Drug Eluting Devices by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Peripheral Intervention Drug Eluting Devices Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Peripheral Intervention Drug Eluting Devices by Type (2026-2035)
12.1.2 Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Peripheral Intervention Drug Eluting Devices by Type (2026-2035)
12.2 Global Peripheral Intervention Drug Eluting Devices Market Forecast by Application (2026-2035)
12.2.1 Global Peripheral Intervention Drug Eluting Devices Sales (K Units) Forecast by Application
12.2.2 Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Peripheral Intervention Drug Eluting Devices Market Size by Type (M USD)
Table 4. Global Peripheral Intervention Drug Eluting Devices Market Size by Application
Table 5. Peripheral Intervention Drug Eluting Devices Market Size Comparison by Region (M USD)
Table 6. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Peripheral Intervention Drug Eluting Devices Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Peripheral Intervention Drug Eluting Devices Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Intervention Drug Eluting Devices as of 2025)
Table 11. Global Market Peripheral Intervention Drug Eluting Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Peripheral Intervention Drug Eluting Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peripheral Intervention Drug Eluting Devices Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Peripheral Intervention Drug Eluting Devices Sales by Type (K Units)
Table 27. Global Peripheral Intervention Drug Eluting Devices Market Size by Type (M USD)
Table 28. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) by Type (2020-2025)
Table 29. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Type (2020-2025)
Table 30. Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) by Type (2020-2025)
Table 31. Global Peripheral Intervention Drug Eluting Devices Market Share by Type (2020-2025)
Table 32. Global Peripheral Intervention Drug Eluting Devices Price (USD/Unit) by Type (2020-2025)
Table 33. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) by Application
Table 34. Global Peripheral Intervention Drug Eluting Devices Market Size by Application
Table 35. Global Peripheral Intervention Drug Eluting Devices Sales by Application (2020-2025) & (K Units)
Table 36. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Application (2020-2025)
Table 37. Global Peripheral Intervention Drug Eluting Devices Market Size by Application (2020-2025) & (M USD)
Table 38. Global Peripheral Intervention Drug Eluting Devices Market Share by Application (2020-2025)
Table 39. Global Peripheral Intervention Drug Eluting Devices Sales Growth Rate by Application (2020-2025)
Table 40. Global Peripheral Intervention Drug Eluting Devices Sales by Region (2020-2025) & (K Units)
Table 41. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Region (2020-2025)
Table 42. Global Peripheral Intervention Drug Eluting Devices Market Size by Region (2020-2025) & (M USD)
Table 43. Global Peripheral Intervention Drug Eluting Devices Market Size by Region (2020-2025)
Table 44. North America Peripheral Intervention Drug Eluting Devices Sales by Country (2020-2025) & (K Units)
Table 45. North America Peripheral Intervention Drug Eluting Devices Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Peripheral Intervention Drug Eluting Devices Sales by Country (2020-2025) & (K Units)
Table 47. Europe Peripheral Intervention Drug Eluting Devices Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Peripheral Intervention Drug Eluting Devices Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Peripheral Intervention Drug Eluting Devices Market Size by Region (2020-2025) & (M USD)
Table 50. South America Peripheral Intervention Drug Eluting Devices Sales by Country (2020-2025) & (K Units)
Table 51. South America Peripheral Intervention Drug Eluting Devices Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Peripheral Intervention Drug Eluting Devices Market Size by Region (2020-2025) & (M USD)
Table 54. Global Peripheral Intervention Drug Eluting Devices Production (K Units) by Region(2020-2025)
Table 55. Global Peripheral Intervention Drug Eluting Devices Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Peripheral Intervention Drug Eluting Devices Revenue Market Share by Region (2020-2025)
Table 57. Global Peripheral Intervention Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Peripheral Intervention Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Peripheral Intervention Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Peripheral Intervention Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Peripheral Intervention Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Medtronic plc Basic Information
Table 63. Medtronic plc Peripheral Intervention Drug Eluting Devices Product Overview
Table 64. Medtronic plc Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Medtronic plc Business Overview
Table 66. Medtronic plc SWOT Analysis
Table 67. Medtronic plc Recent Developments
Table 68. Boston Scientific Corporation Basic Information
Table 69. Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Product Overview
Table 70. Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Boston Scientific Corporation Business Overview
Table 72. Boston Scientific Corporation SWOT Analysis
Table 73. Boston Scientific Corporation Recent Developments
Table 74. Abbott Laboratories Basic Information
Table 75. Abbott Laboratories Peripheral Intervention Drug Eluting Devices Product Overview
Table 76. Abbott Laboratories Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories SWOT Analysis
Table 79. Abbott Laboratories Recent Developments
Table 80. Cardinal Health Basic Information
Table 81. Cardinal Health Peripheral Intervention Drug Eluting Devices Product Overview
Table 82. Cardinal Health Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Cardinal Health Business Overview
Table 84. Cardinal Health Recent Developments
Table 85. B. Braun Melsungen AG Basic Information
Table 86. B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Product Overview
Table 87. B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. B. Braun Melsungen AG Business Overview
Table 89. B. Braun Melsungen AG Recent Developments
Table 90. Biosensors International Group Ltd. Basic Information
Table 91. Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Product Overview
Table 92. Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Biosensors International Group Ltd. Business Overview
Table 94. Biosensors International Group Ltd. Recent Developments
Table 95. C.R. BardInc. Basic Information
Table 96. C.R. BardInc. Peripheral Intervention Drug Eluting Devices Product Overview
Table 97. C.R. BardInc. Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. C.R. BardInc. Business Overview
Table 99. C.R. BardInc. Recent Developments
Table 100. Abbott Basic Information
Table 101. Abbott Peripheral Intervention Drug Eluting Devices Product Overview
Table 102. Abbott Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Abbott Business Overview
Table 104. Abbott Recent Developments
Table 105. The Lubrizol Corporation Basic Information
Table 106. The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Product Overview
Table 107. The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. The Lubrizol Corporation Business Overview
Table 109. The Lubrizol Corporation Recent Developments
Table 110. Terumo Corporation Basic Information
Table 111. Terumo Corporation Peripheral Intervention Drug Eluting Devices Product Overview
Table 112. Terumo Corporation Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Terumo Corporation Business Overview
Table 114. Terumo Corporation Recent Developments
Table 115. Global Peripheral Intervention Drug Eluting Devices Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Peripheral Intervention Drug Eluting Devices Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Peripheral Intervention Drug Eluting Devices Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Peripheral Intervention Drug Eluting Devices Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Peripheral Intervention Drug Eluting Devices Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Peripheral Intervention Drug Eluting Devices Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Peripheral Intervention Drug Eluting Devices Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Peripheral Intervention Drug Eluting Devices Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Peripheral Intervention Drug Eluting Devices Market Size by Type (M USD)
Table 4. Global Peripheral Intervention Drug Eluting Devices Market Size by Application
Table 5. Peripheral Intervention Drug Eluting Devices Market Size Comparison by Region (M USD)
Table 6. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Peripheral Intervention Drug Eluting Devices Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Peripheral Intervention Drug Eluting Devices Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Intervention Drug Eluting Devices as of 2025)
Table 11. Global Market Peripheral Intervention Drug Eluting Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Peripheral Intervention Drug Eluting Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peripheral Intervention Drug Eluting Devices Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Peripheral Intervention Drug Eluting Devices Sales by Type (K Units)
Table 27. Global Peripheral Intervention Drug Eluting Devices Market Size by Type (M USD)
Table 28. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) by Type (2020-2025)
Table 29. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Type (2020-2025)
Table 30. Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) by Type (2020-2025)
Table 31. Global Peripheral Intervention Drug Eluting Devices Market Share by Type (2020-2025)
Table 32. Global Peripheral Intervention Drug Eluting Devices Price (USD/Unit) by Type (2020-2025)
Table 33. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) by Application
Table 34. Global Peripheral Intervention Drug Eluting Devices Market Size by Application
Table 35. Global Peripheral Intervention Drug Eluting Devices Sales by Application (2020-2025) & (K Units)
Table 36. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Application (2020-2025)
Table 37. Global Peripheral Intervention Drug Eluting Devices Market Size by Application (2020-2025) & (M USD)
Table 38. Global Peripheral Intervention Drug Eluting Devices Market Share by Application (2020-2025)
Table 39. Global Peripheral Intervention Drug Eluting Devices Sales Growth Rate by Application (2020-2025)
Table 40. Global Peripheral Intervention Drug Eluting Devices Sales by Region (2020-2025) & (K Units)
Table 41. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Region (2020-2025)
Table 42. Global Peripheral Intervention Drug Eluting Devices Market Size by Region (2020-2025) & (M USD)
Table 43. Global Peripheral Intervention Drug Eluting Devices Market Size by Region (2020-2025)
Table 44. North America Peripheral Intervention Drug Eluting Devices Sales by Country (2020-2025) & (K Units)
Table 45. North America Peripheral Intervention Drug Eluting Devices Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Peripheral Intervention Drug Eluting Devices Sales by Country (2020-2025) & (K Units)
Table 47. Europe Peripheral Intervention Drug Eluting Devices Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Peripheral Intervention Drug Eluting Devices Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Peripheral Intervention Drug Eluting Devices Market Size by Region (2020-2025) & (M USD)
Table 50. South America Peripheral Intervention Drug Eluting Devices Sales by Country (2020-2025) & (K Units)
Table 51. South America Peripheral Intervention Drug Eluting Devices Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Peripheral Intervention Drug Eluting Devices Market Size by Region (2020-2025) & (M USD)
Table 54. Global Peripheral Intervention Drug Eluting Devices Production (K Units) by Region(2020-2025)
Table 55. Global Peripheral Intervention Drug Eluting Devices Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Peripheral Intervention Drug Eluting Devices Revenue Market Share by Region (2020-2025)
Table 57. Global Peripheral Intervention Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Peripheral Intervention Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Peripheral Intervention Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Peripheral Intervention Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Peripheral Intervention Drug Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Medtronic plc Basic Information
Table 63. Medtronic plc Peripheral Intervention Drug Eluting Devices Product Overview
Table 64. Medtronic plc Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Medtronic plc Business Overview
Table 66. Medtronic plc SWOT Analysis
Table 67. Medtronic plc Recent Developments
Table 68. Boston Scientific Corporation Basic Information
Table 69. Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Product Overview
Table 70. Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Boston Scientific Corporation Business Overview
Table 72. Boston Scientific Corporation SWOT Analysis
Table 73. Boston Scientific Corporation Recent Developments
Table 74. Abbott Laboratories Basic Information
Table 75. Abbott Laboratories Peripheral Intervention Drug Eluting Devices Product Overview
Table 76. Abbott Laboratories Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories SWOT Analysis
Table 79. Abbott Laboratories Recent Developments
Table 80. Cardinal Health Basic Information
Table 81. Cardinal Health Peripheral Intervention Drug Eluting Devices Product Overview
Table 82. Cardinal Health Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Cardinal Health Business Overview
Table 84. Cardinal Health Recent Developments
Table 85. B. Braun Melsungen AG Basic Information
Table 86. B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Product Overview
Table 87. B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. B. Braun Melsungen AG Business Overview
Table 89. B. Braun Melsungen AG Recent Developments
Table 90. Biosensors International Group Ltd. Basic Information
Table 91. Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Product Overview
Table 92. Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Biosensors International Group Ltd. Business Overview
Table 94. Biosensors International Group Ltd. Recent Developments
Table 95. C.R. BardInc. Basic Information
Table 96. C.R. BardInc. Peripheral Intervention Drug Eluting Devices Product Overview
Table 97. C.R. BardInc. Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. C.R. BardInc. Business Overview
Table 99. C.R. BardInc. Recent Developments
Table 100. Abbott Basic Information
Table 101. Abbott Peripheral Intervention Drug Eluting Devices Product Overview
Table 102. Abbott Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Abbott Business Overview
Table 104. Abbott Recent Developments
Table 105. The Lubrizol Corporation Basic Information
Table 106. The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Product Overview
Table 107. The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. The Lubrizol Corporation Business Overview
Table 109. The Lubrizol Corporation Recent Developments
Table 110. Terumo Corporation Basic Information
Table 111. Terumo Corporation Peripheral Intervention Drug Eluting Devices Product Overview
Table 112. Terumo Corporation Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Terumo Corporation Business Overview
Table 114. Terumo Corporation Recent Developments
Table 115. Global Peripheral Intervention Drug Eluting Devices Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Peripheral Intervention Drug Eluting Devices Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Peripheral Intervention Drug Eluting Devices Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Peripheral Intervention Drug Eluting Devices Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Peripheral Intervention Drug Eluting Devices Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Peripheral Intervention Drug Eluting Devices Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Peripheral Intervention Drug Eluting Devices Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Peripheral Intervention Drug Eluting Devices Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Peripheral Intervention Drug Eluting Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peripheral Intervention Drug Eluting Devices Market Size (M USD), 2025-2035
Figure 5. Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) (2020-2035)
Figure 6. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peripheral Intervention Drug Eluting Devices Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Peripheral Intervention Drug Eluting Devices Product Life Cycle
Figure 13. Peripheral Intervention Drug Eluting Devices Sales Share by Manufacturers in 2025
Figure 14. Global Peripheral Intervention Drug Eluting Devices Revenue Share by Manufacturers in 2025
Figure 15. Peripheral Intervention Drug Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Peripheral Intervention Drug Eluting Devices Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Peripheral Intervention Drug Eluting Devices Revenue in 2025
Figure 18. Industry Chain Map of Peripheral Intervention Drug Eluting Devices
Figure 19. Global Peripheral Intervention Drug Eluting Devices Market PEST Analysis
Figure 20. Global Peripheral Intervention Drug Eluting Devices Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Peripheral Intervention Drug Eluting Devices Market Share by Type
Figure 27. Sales Market Share of Peripheral Intervention Drug Eluting Devices by Type (2020-2025)
Figure 28. Sales Market Share of Peripheral Intervention Drug Eluting Devices by Type in 2025
Figure 29. Market Share of Peripheral Intervention Drug Eluting Devices by Type (2020-2025)
Figure 30. Market Share of Peripheral Intervention Drug Eluting Devices by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Peripheral Intervention Drug Eluting Devices Market Share by Application
Figure 33. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Application (2020-2025)
Figure 34. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Application in 2025
Figure 35. Global Peripheral Intervention Drug Eluting Devices Market Share by Application (2020-2025)
Figure 36. Global Peripheral Intervention Drug Eluting Devices Market Share by Application in 2025
Figure 37. Global Peripheral Intervention Drug Eluting Devices Sales Growth Rate by Application (2020-2025)
Figure 38. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Region (2020-2025)
Figure 39. Global Peripheral Intervention Drug Eluting Devices Market Size by Region (2020-2025)
Figure 40. North America Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Peripheral Intervention Drug Eluting Devices Sales Market Share by Country in 2024
Figure 43. North America Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Peripheral Intervention Drug Eluting Devices Market Size by Country in 2024
Figure 45. U.S. Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Peripheral Intervention Drug Eluting Devices Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Peripheral Intervention Drug Eluting Devices Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Peripheral Intervention Drug Eluting Devices Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Peripheral Intervention Drug Eluting Devices Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Peripheral Intervention Drug Eluting Devices Sales Market Share by Country in 2024
Figure 53. Europe Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Peripheral Intervention Drug Eluting Devices Market Size by Country in 2024
Figure 55. Germany Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Peripheral Intervention Drug Eluting Devices Sales Market Share by Region in 2024
Figure 67. Asia Pacific Peripheral Intervention Drug Eluting Devices Market Size by Region in 2024
Figure 68. China Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (K Units)
Figure 79. South America Peripheral Intervention Drug Eluting Devices Sales Market Share by Country in 2024
Figure 80. South America Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (M USD)
Figure 81. South America Peripheral Intervention Drug Eluting Devices Market Size by Country in 2024
Figure 82. Brazil Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Peripheral Intervention Drug Eluting Devices Market Size by Region in 2024
Figure 92. Saudi Arabia Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Peripheral Intervention Drug Eluting Devices Production Market Share by Region (2020-2025)
Figure 103. North America Peripheral Intervention Drug Eluting Devices Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Peripheral Intervention Drug Eluting Devices Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Peripheral Intervention Drug Eluting Devices Production (K Units) Growth Rate (2020-2025)
Figure 106. China Peripheral Intervention Drug Eluting Devices Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Peripheral Intervention Drug Eluting Devices Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Peripheral Intervention Drug Eluting Devices Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Peripheral Intervention Drug Eluting Devices Market Share Forecast by Type (2026-2035)
Figure 111. Global Peripheral Intervention Drug Eluting Devices Sales Forecast by Application (2026-2035)
Figure 112. Global Peripheral Intervention Drug Eluting Devices Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Peripheral Intervention Drug Eluting Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peripheral Intervention Drug Eluting Devices Market Size (M USD), 2025-2035
Figure 5. Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) (2020-2035)
Figure 6. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peripheral Intervention Drug Eluting Devices Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Peripheral Intervention Drug Eluting Devices Product Life Cycle
Figure 13. Peripheral Intervention Drug Eluting Devices Sales Share by Manufacturers in 2025
Figure 14. Global Peripheral Intervention Drug Eluting Devices Revenue Share by Manufacturers in 2025
Figure 15. Peripheral Intervention Drug Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Peripheral Intervention Drug Eluting Devices Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Peripheral Intervention Drug Eluting Devices Revenue in 2025
Figure 18. Industry Chain Map of Peripheral Intervention Drug Eluting Devices
Figure 19. Global Peripheral Intervention Drug Eluting Devices Market PEST Analysis
Figure 20. Global Peripheral Intervention Drug Eluting Devices Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Peripheral Intervention Drug Eluting Devices Market Share by Type
Figure 27. Sales Market Share of Peripheral Intervention Drug Eluting Devices by Type (2020-2025)
Figure 28. Sales Market Share of Peripheral Intervention Drug Eluting Devices by Type in 2025
Figure 29. Market Share of Peripheral Intervention Drug Eluting Devices by Type (2020-2025)
Figure 30. Market Share of Peripheral Intervention Drug Eluting Devices by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Peripheral Intervention Drug Eluting Devices Market Share by Application
Figure 33. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Application (2020-2025)
Figure 34. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Application in 2025
Figure 35. Global Peripheral Intervention Drug Eluting Devices Market Share by Application (2020-2025)
Figure 36. Global Peripheral Intervention Drug Eluting Devices Market Share by Application in 2025
Figure 37. Global Peripheral Intervention Drug Eluting Devices Sales Growth Rate by Application (2020-2025)
Figure 38. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Region (2020-2025)
Figure 39. Global Peripheral Intervention Drug Eluting Devices Market Size by Region (2020-2025)
Figure 40. North America Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Peripheral Intervention Drug Eluting Devices Sales Market Share by Country in 2024
Figure 43. North America Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Peripheral Intervention Drug Eluting Devices Market Size by Country in 2024
Figure 45. U.S. Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Peripheral Intervention Drug Eluting Devices Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Peripheral Intervention Drug Eluting Devices Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Peripheral Intervention Drug Eluting Devices Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Peripheral Intervention Drug Eluting Devices Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Peripheral Intervention Drug Eluting Devices Sales Market Share by Country in 2024
Figure 53. Europe Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Peripheral Intervention Drug Eluting Devices Market Size by Country in 2024
Figure 55. Germany Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Peripheral Intervention Drug Eluting Devices Sales Market Share by Region in 2024
Figure 67. Asia Pacific Peripheral Intervention Drug Eluting Devices Market Size by Region in 2024
Figure 68. China Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (K Units)
Figure 79. South America Peripheral Intervention Drug Eluting Devices Sales Market Share by Country in 2024
Figure 80. South America Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (M USD)
Figure 81. South America Peripheral Intervention Drug Eluting Devices Market Size by Country in 2024
Figure 82. Brazil Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Peripheral Intervention Drug Eluting Devices Market Size by Region in 2024
Figure 92. Saudi Arabia Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Peripheral Intervention Drug Eluting Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Peripheral Intervention Drug Eluting Devices Production Market Share by Region (2020-2025)
Figure 103. North America Peripheral Intervention Drug Eluting Devices Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Peripheral Intervention Drug Eluting Devices Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Peripheral Intervention Drug Eluting Devices Production (K Units) Growth Rate (2020-2025)
Figure 106. China Peripheral Intervention Drug Eluting Devices Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Peripheral Intervention Drug Eluting Devices Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Peripheral Intervention Drug Eluting Devices Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Peripheral Intervention Drug Eluting Devices Market Share Forecast by Type (2026-2035)
Figure 111. Global Peripheral Intervention Drug Eluting Devices Sales Forecast by Application (2026-2035)
Figure 112. Global Peripheral Intervention Drug Eluting Devices Market Share Forecast by Application (2026-2035)
